Annotation Detail for ZSCAN12
Basic Information
TopGene Symbol: | ZSCAN12 ( KIAA0426,ZFP96,ZNF29K1,ZNF305,ZNF96,dJ29K1.2 ) |
---|
Gene Full Name: | zinc finger and SCAN domain containing 12 |
---|
Band: | 6p22.1 |
---|
Quick Links | Entrez ID:9753; OMIM: 603978; Uniprot ID:; ENSEMBL ID: ENSG00000158691; HGNC ID: 13172 |
---|
Relate to Another Database: |
SFARIGene;
denovo-db |
Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of ZSCAN12 mRNA | affects expression | 16483693
|
C014347 |
decitabine |
[decitabine co-treated with trichostatin A] inhibits the reaction [sodium arsenite affects the methylation of ZSCAN12 promoter] | affects cotreatment|affects methylation|decreases reaction | 18448484
|
C014347 |
decitabine |
decitabine inhibits the reaction [sodium arsenite affects the methylation of ZSCAN12 promoter] | affects methylation|decreases reaction | 18448484
|
D005419 |
Flavonoids |
Flavonoids results in decreased expression of ZSCAN12 mRNA | decreases expression | 18035473
|
C406082 |
monomethylarsonous acid |
[monomethylarsonous acid affects the acetylation of HIST3H3 protein] which affects the methylation of ZSCAN12 promoter | affects acetylation|affects methylation | 18448484
|
C406082 |
monomethylarsonous acid |
monomethylarsonous acid results in decreased expression of ZSCAN12 mRNA | decreases expression | 18448484
|
C017947 |
sodium arsenite |
[decitabine co-treated with trichostatin A] inhibits the reaction [sodium arsenite affects the methylation of ZSCAN12 promoter] | affects cotreatment|affects methylation|decreases reaction | 18448484
|
C017947 |
sodium arsenite |
decitabine inhibits the reaction [sodium arsenite affects the methylation of ZSCAN12 promoter] | affects methylation|decreases reaction | 18448484
|
C017947 |
sodium arsenite |
[sodium arsenite affects the acetylation of HIST3H3 protein] which affects the methylation of ZSCAN12 promoter | affects acetylation|affects methylation | 18448484
|
C017947 |
sodium arsenite |
sodium arsenite results in decreased expression of ZSCAN12 mRNA | decreases expression | 18448484
|
C012589 |
trichostatin A |
[decitabine co-treated with trichostatin A] inhibits the reaction [sodium arsenite affects the methylation of ZSCAN12 promoter] | affects cotreatment|affects methylation|decreases reaction | 18448484
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
4.02 | 18287403 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
5.22 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
5.42 | 16712894 17306315 |
MESH:D001943 |
Breast Neoplasms |
|
decitabine |
2.54 | 18320071 19208741 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
2.00 | 15276417 17306315 16507464 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
decitabine |
5.05 | 19215824 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
5.05 | 18572023 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
monomethylarsonous acid |
7.87 | 19716837 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
7.87 | 19524636 20056578 |
MESH:D003110 |
Colonic Neoplasms |
|
decitabine |
2.37 | 17616700 |
MESH:D015179 |
Colorectal Neoplasms |
|
decitabine |
2.10 | 18981723 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
decitabine |
15.83 | 19294695 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
trichostatin A |
15.83 | 19294695 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
5.14 | 16452187 |
MESH:D005909 |
Glioblastoma |
|
trichostatin A |
4.02 | 18801729 |
MESH:D006258 |
Head and Neck Neoplasms |
|
decitabine |
3.69 | 19215824 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
3.43 | 12676792 |
MESH:D007248 |
Infertility, Male |
|
decitabine |
7.58 | 17581917 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
7.58 | 12646999 15346721 |
MESH:D007249 |
Inflammation |
|
Flavonoids |
2.79 | 17296493 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
2.96 | 20008137 |
MESH:D007938 |
Leukemia |
|
decitabine |
3.21 | 18980019 19235587 |
MESH:D007951 |
Leukemia, Myeloid |
|
decitabine |
4.33 | 17236224 19117987 18454857 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
decitabine |
4.43 | 18460780 18704418 17679729 18206229 19010910 19387464 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
trichostatin A |
4.43 | 18206229 |
MESH:D015477 |
Leukemia, Myelomonocytic, Chronic |
|
decitabine |
5.98 | 18055864 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
2.46 | 15276417 16712894 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
3.37 | 19095001 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
1.90 | 19931552 16712894 15276417 17306315 17077188 |
MESH:D008223 |
Lymphoma |
|
decitabine |
3.64 | 19470736 |
MESH:D008545 |
Melanoma |
|
decitabine |
5.52 | 17785578 16505122 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
5.52 | 19082730 16487513 |
MESH:D008545 |
Melanoma |
|
trichostatin A |
5.52 | 16505122 |
MESH:D009101 |
Multiple Myeloma |
|
decitabine |
8.39 | 18172295 |
MESH:D009101 |
Multiple Myeloma |
|
trichostatin A |
8.39 | 18172295 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
decitabine |
3.54 | 19157545 18608210 19010910 16882708 |
MESH:D009369 |
Neoplasms |
|
decitabine |
5.68 | 19116145 17925555 19470736 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
5.68 | 11559025 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
4.08 | 20056578 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
3.33 | 12854658 |
MESH:D010051 |
Ovarian Neoplasms |
|
decitabine |
8.52 | 19331143 19259094 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
8.52 | 17306315 15276417 |
MESH:D010051 |
Ovarian Neoplasms |
|
trichostatin A |
8.52 | 19331143 |
MESH:D010190 |
Pancreatic Neoplasms |
|
decitabine |
5.99 | 19294695 |
MESH:D010190 |
Pancreatic Neoplasms |
|
trichostatin A |
5.99 | 19294695 |
MESH:D055728 |
Primary Myelofibrosis |
|
decitabine |
13.86 | 17616702 |
MESH:D055728 |
Primary Myelofibrosis |
|
trichostatin A |
13.86 | 17616702 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
3.51 | 16039940 |
MESH:D011471 |
Prostatic Neoplasms |
|
trichostatin A |
3.51 | 19789329 18798265 |
MESH:D012208 |
Rhabdomyosarcoma |
|
decitabine |
4.75 | 19155313 |
MESH:D012871 |
Skin Diseases |
|
monomethylarsonous acid |
3.44 | 17431481 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
2.82 | 18572023 19524636 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
4.04 | 12854658 |
MESH:D013274 |
Stomach Neoplasms |
|
decitabine |
2.10 | 19037991 |
MESH:D013964 |
Thyroid Neoplasms |
|
decitabine |
3.57 | 17967635 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
decitabine |
9.13 | 19087683 17616700 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
monomethylarsonous acid |
9.13 | 20375083 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
9.13 | 17306315 16452187 16712894 11723127 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
4.07 | 11813266 |
MESH:D014604 |
Uveal Neoplasms |
|
decitabine |
5.43 | 17785578 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.89 | 17056641 |